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Attention deficit hyperactivity disorder 
(ADHD) is the most common neurobehav-
ioral disorder in childhood, affecting large 
numbers of children throughout the world.
Because of the knowledge evolved from 
ADHD research, today’s challenges are vast, 
including changes in terminology, fears of 
over-diagnosis, and over-medication of 
children.
What began as a case description, has 
now evolved in clinical trials, leading from 
observations of behavior to advances in 
neuroscience. The biggest challenge remains 
in the correct diagnosis of ADHD, though.
With a worldwide prevalence of 
approximately 5%, ADHD is very com-
mon (Polanczyk et al., 2007). ADHD in 
the United States even shows a prevalence 
among 8- to 15-years-olds of 8.7% and 
only a third of the ADHD patients have 
been treated consistently during the past 
year (Froehlich et al., 2007). In another age 
group (18- to 44-year-olds) the prevalence 
is about 4.4% (Kessler et al., 2006).
Male patients are six times more often 
diagnosed with ADHD in childhood than 
female patients and three times more often 
in the adolescence. The prevalence seems to 
be equivalent in all levels of IQ and socio-
economic status (Gaub and Carlson, 1997; 
Levy et al., 1997; Smalley et al., 2000; Pastor 
and Reuben, 2008).
The core symptoms of ADHD in DSM-
IV-TR criteria (American Psychiatric 
Association, 2000) include inattention on 
the one hand and hyperactivity and impul-
sivity on the other hand, both having to be 
consistent to a degree that is maladaptive 
and inconsistent with developmental level, 
e.g., a 3-year-old’s behavior is to be expected 
different from an 8-year-old’s behavior.
Additional criteria include the chro-
nicity of ADHD symptoms, meaning that 
there has to be a persistence of  symptoms 
at least for 6 months, pervasiveness of 
ADHD symptoms (ADHD symptoms 
have to be present in different settings and 
locations, or at least in more than one loca-
tion, e.g., family, community, workplace), 
some hyperactive-impulsive or inattentive 
symptoms must have been present before 
the age of 7 years and there must be clear 
evidence of interference with developmen-
tally appropriate social, academic, or occu-
pational functioning, e.g., you may have one 
of the symptoms, but if it is not impairing 
you or interfering with your functioning, 
a diagnosis cannot be made. At last but 
not least, the disturbance does not occur 
exclusively during the course of other seri-
ous mental disorders (e.g., pervasive devel-
opmental disorder/autism, schizophrenia, 
other psychotic disorder).
In the current DSM, there are three dif-
ferent ways of diagnosing ADHD. There is 
the combined type, e.g., both core symp-
toms are met for the past 6 months; there 
is the predominantly inattentive type and 
finally the predominantly hyperactive-
impulsive type.
But what are the strengths of DSM-IV 
criteria? The committee of experts that 
has developed the DSM-IV criteria cata-
log clearly uses rigorous and empirically 
derived criteria, has looked at all rat-
ing scales for diagnosing ADHD and has 
reviewed the ADHD literature. Additionally, 
the impairment criterion has been given 
greater emphasis in the past few years.
Nevertheless there are certain weaknesses 
and controversies of DSM-IV criteria and it 
is important to have a second look: the age 
of onset criterion may not be justified (the 
age of 7 years does seem very restrictive), 
diagnostic item sets may be inappropriate 
for different developmental periods (e.g., 
not being able to sit quietly in a chair does 
not seem to be the right diagnostic item set 
for an adult, he does not need to listen or 
doesn’t want to), diagnostic thresholds may 
not apply to older age groups (>16 years), 
there is no gender distinction in diagnostic 
thresholds and there is no lower age limit 
defined (<4 years).
So what are potential changes in DSM 5 
criteria (American Psychiatric Association, 
2013)? For a start, the age onset criterion 
shall be increased from 7 years of age to 
12 years of age. Then there is the intent 
to contextualize and illustrate diagnostic 
item sets to fit lifespan (e.g., inattention 
in a child versus an adolescent versus an 
adult). Additionally, there are up to four 
new criteria for impulsivity (there have 
been only three dimensions compared to 
inattention or hyperactivity). And finally, 
the number of criteria needed for adoles-
cents and adults is likely to be revised, for 
data has suggested two to three from all 
three dimensions (subtypes for inatten-
tion, hyperactivity, and impulsivity) would 
be best, which will probably increase the 
prevalence dramatically.
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